The economic consequences of US FDA new drug approvals : evidence from Taiwan pharmaceutical and biotech companies
Year of publication: |
2021
|
---|---|
Authors: | Chen, Yong-Jie ; Feng, Zhi-Yuan ; Li, Yueh-Ping ; Huang, Hua Wei |
Published in: |
Innovation: organization & management : IOM. - Abingdon, Oxon : Routledge, Taylor & Francis, ISSN 2204-0226, ZDB-ID 2180355-9. - Vol. 23.2021, 3, p. 354-374
|
Subject: | accounting regulations | FDA approvals | healthcare policy | pharmaceutical companies | research and development investment | stock price returns | tax incentive | USA | United States | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Industrieforschung | Industrial research | Arzneimittelrecht | Pharmaceutical law | Taiwan | Pharmakologie | Pharmacology | Börsenkurs | Share price | Biotechnologie-Industrie | Biotechnology industry |
-
FDA approval announcements : attention-grabbing or event-day misspecification?
Hamill, Philip, (2018)
-
Hemphill, Thomas A., (2013)
-
Michaeli, Daniel, (2024)
- More ...
-
The association between financial activities and self-rated health in middle-aged and older adults
Li, Yueh-Ping, (2022)
-
Global-level auditor industry specialization and the cost of equity capital
Feng, Zhi-Yuan, (2023)
-
Gender and financial activities for middle-aged and older adults
Li, Yueh-Ping, (2023)
- More ...